Newgenivf Group Limited - Class A (NIVF) closed at $0.15 on October 22, 2026, down 20.8% from the previous close, on volume of 1,461,292 shares (30-day average 60,266,708).
Data as of October 22, 2026.
NewGenIvf Group to Implement One-for-Eight Reverse Stock Split on October 23, 2026
TipRanks (Wed, 21-Oct 8:28 AM ET)
NewGen Announces Closing of $1.25 Million Public Offering
Globe Newswire (Wed, 30-Sep 2:10 PM ET)
NewGen Announces Pricing of $1.25 Million Public Offering
Globe Newswire (Mon, 28-Sep 10:30 PM ET)
NewGenIVF Completes Exchange of Convertible Notes with Institutional Investor
Globe Newswire (Mon, 17-Aug 8:30 AM ET)
NewGen Provides Update on K25.ai Investment and Strengthened Financial Position
Globe Newswire (Thu, 30-Jul 8:30 AM ET)
Globe Newswire (Mon, 27-Jul 8:30 AM ET)
Globe Newswire (Thu, 23-Jul 8:30 AM ET)
PRNewswire (Thu, 23-Jul 4:37 AM ET)
Market Chameleon (Tue, 16-Jun 5:53 AM ET)
NIVF Invests in K25.ai's $100M Valuation, Targeting APAC Leadership in AI-Powered Prediction Markets
Market Chameleon (Thu, 21-May 5:53 AM ET)
NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services. It derives maximum revenue from in vitro fertilization (IVF) treatment service. Its Geographical presence is in China / HK SAR, Thailand, Cambodia, U.S and Kyrgyzstan. The company derives maximum revenue from Kyrgyzstan.
Newgenivf Group Limited - Class A trades on the NASDAQ stock market under the symbol NIVF.
As of October 22, 2026, NIVF stock price declined to $0.15 with 1,461,292 million shares trading.
NIVF has a beta of 4.14, meaning it tends to be more sensitive to market movements. NIVF has a correlation of 0.04 to the broad based SPY ETF.
NIVF has a market cap of $1.02 million. This is considered a Sub-Micro Cap stock.
NIVF has underperformed the market in the last year with a price return of -99.9% while the SPY ETF gained +14.9%. NIVF has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -99.0% and -64.9%, respectively, while the SPY returned +2.3% and -1.7%, respectively.
NIVF support price is $.13 and resistance is $.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NIVF shares will trade within this expected range on the day.
